etoposide phosphate has been researched along with Allergy, Drug in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilbar, PJ; Grewal, GD; Pringle, NR | 1 |
| Azmy, V; Brooks, JP; Hsu, FI; Luon, D; Price, C; Prozora, SD; Thompson, A | 1 |
| Kokache, A; Mahmoud, S; Sambasivan, K; Savage, P; Seckl, M | 1 |
| Bourneau-Martin, D; Drablier, G; Lagarce, L; Lainé-Cessac, P; Le Louet, H; Leguay, Z; Pellier, I | 1 |
| Cirillo, M; O'Sullivan, M; Polistena, P; Purtill, D; Tran, Q | 1 |
| Collier, K; How, K; Savage, P; Schink, C; Seckl, M; Young, AM | 1 |
| Bernstein, BJ; Troner, MB | 1 |
| De Boer, R; Desai, J; Prasad, P; Siderov, J | 1 |
1 review(s) available for etoposide phosphate and Allergy, Drug
| Article | Year |
|---|---|
Immediate severe hypersensitivity reaction to etoposide phosphate: Case report and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Hypersensitivity; Etoposide; Humans; Male; Organophosphorus Compounds; Young Adult | 2022 |
7 other study(ies) available for etoposide phosphate and Allergy, Drug
| Article | Year |
|---|---|
Etoposide phosphate for pediatric orthopedic malignancies after intravenous etoposide hypersensitivity.
Topics: Adolescent; Bone Neoplasms; Drug Hypersensitivity; Etoposide; Humans; Male; Organophosphorus Compounds; Osteosarcoma; Sarcoma, Ewing | 2020 |
Hypersensitivity reactions to etoposide phosphate.
Topics: Adult; Antineoplastic Agents; Drug Hypersensitivity; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Organophosphorus Compounds; Young Adult | 2014 |
Successful Treatment with Etoposide Base after an Acute Hypersensitivity Reaction to Etoposide Phosphate.
Topics: Acute Disease; Benzyl Alcohols; Carboplatin; Child, Preschool; Drug Hypersensitivity; Etoposide; Female; Humans; Infusions, Intravenous; Medulloblastoma; Organophosphorus Compounds | 2016 |
Etoposide phosphate hypersensitivity overcome using a desensitisation programme enabling optimal therapy for relapsed Hodgkin lymphoma.
Topics: Adult; Desensitization, Immunologic; Drug Hypersensitivity; Etoposide; Hodgkin Disease; Humans; Male; Organophosphorus Compounds; Recurrence | 2017 |
Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity.
Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Chlorpheniramine; Drug Hypersensitivity; Etoposide; Female; Humans; Hydrocortisone; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Organophosphorus Compounds | 2008 |
Successful rechallenge with etoposide phosphate after an acute hypersensitivity reaction to etoposide.
Topics: Adult; Antineoplastic Agents; Drug Hypersensitivity; Etoposide; Female; Humans; Organophosphorus Compounds | 1999 |
Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide.
Topics: Adult; Antineoplastic Agents; Drug Hypersensitivity; Etoposide; Humans; Infusions, Intravenous; Male; Organophosphorus Compounds | 2002 |